参考文献/References:
1 Delbeke D, Martin WH. PET and PET-CT for evaluation of colorectal carcinoma. Semin Nucl Med, 2004, 34(3):209-223.
2 Even-Sapir E, Lerman H, Figer A, et al. Role of (18)F-FDG dualhead gamma-camera coincidence imaging in recurrent or metastatic colorectal carcinoma. J Nucl Med, 2002, 43(5):603-609.
3 Esteves FP, Schuster DM, Halkar RK, et al. Gastrointestinal tract malignancies and positron emission tomography:an overview.Semin Nucl Med, 2006, 36(2):169-181.
4 Zervos EE, Badgwell BD, Burak WE Jr, et al. Fluorodeoxyglucose positron emission tomography as an adjunct to carcinoembryonic antigen in the management of patients with presumed recurrent colorectal cancer and nondiagnostic radiologic workup. Surgery,2001, 130(4):636-643.
5 Flamen P, Hoekstra OS, Homans F, et al. Unexplained rising carcinoembryonic antigen(CEA) in the postoperative surveillance of colorectal cancer:, the utility of positron emission tomography(PET). Eur J Cancer, 2001, 37(7):862-869.
6 Simo M, Lomena F, Setoain J, et al. FDG-PET improves the management of patients with suspected recurrence of colorectal cancer. Nucl Med Commun, 2002, 23(10):975-982.
7 Whiterford MH, Whiteford HM, Yee LF, et al. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocareinoma of the colon and rectum. Dis Colon Rectum, 2000,43(6):759-767.
8 Lonneux M, Reffad AM, Detry R, et al. FDG-PET improves the staging and selection of patients with recurrent colorectal cancer.Eur J Nucl Med Mol Imaging, 2002, 29(7):915-921.
9 Huebner RH, Park KC, Shepherd JE, et al. A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med, 2000, 41(7):1177-1189.
10 Khan S, Tan YM, John A, et al. An audit of fusion CT-PET in the management of colorectal liver metastases. Eur J Surg Oncol, 2006,32(5):564-567.
11 Weng LJ, Akhurst T. Colon cancer metastasis to the adrenal gland demonstrated with FDG PET/CT. Clin Nucl Med, 2004, 29(7)444.
12 Selzner M, Hany TF, Wildbrett P, et al. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver?. Ann Surg, 2004, 240(6):1027-1034.
13 Erturk SM, Ichikawa T, Fujii H, et al. PET imaging for evaluation of metastatic colorectal cancer of the liver. Eur J Radiol, 2006, 58(2):229-235.
14 Tutt AN, Plunker TA, Barrington SF, et al. The role of positron emission tomography in the management of colorectal cancer.Colorectal Dis, 2004, 6(1):2-9.
15 Desai DE, Zervos EE, Arnold MW, et al. Positron emission tomography affects surgical management in recurrent colorectal cancer patients. Ann Surg Oncol, 2003, 10(1):59-64.
16 Even-sapirE, Parag Y, Lerman H, et al. Detection of recurrence in patients with rectal cancer:PET/CT after abdominoperineal or anterior resection. Radiology, 2004, 232(3):815-822.
17 Votrubova J, Belohlavek O, Jaruskova M, et al. The role of FDG-PET/CT in the detection of recurrent colorectal cancer. Eur J Nucl Med Mol Imaging, 2006, 33(7):779-784.
18 Bar-Shalom R, Yefremov N, Guralnik L, et al. Clinical performance of PET/CT in the evaluation of cancer:additional value for diagnostic imaging and patient management. J Nucl Med, 2003, 44(8):1200-1209.
相似文献/References:
[1]黄天骄,史学森,孙凯.CT虚拟结肠镜对早期筛查结直肠癌的研究进展[J].国际放射医学核医学杂志,2016,40(6):474.[doi:10.3760/cma.j.issn.1673-4114.2016.06.014]
Huang Tianjiao,Shi Xuesen,Sun Kai.Research progress of CT virtual colonoscopy for early screening of colorectal neoplasmas[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):474.[doi:10.3760/cma.j.issn.1673-4114.2016.06.014]
[2]马佶赟,石洪成.PET-CT在结直肠癌肝转移诊治中的应用进展[J].国际放射医学核医学杂志,2010,34(4):212.[doi:10.3760/cma.j.issn.1673-4114.2010.04.006]
MA Ji-yun,SHI Hong-cheng.Progress in application of PET-CT in diagnosis and therapy of liver metastasis from colorectal cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(1):212.[doi:10.3760/cma.j.issn.1673-4114.2010.04.006]
[3]胡红永,汤建林,李玉莹,等.肿瘤标志物CEA、CA19-9、CA242联检在结直肠癌患者诊断中的应用[J].国际放射医学核医学杂志,2010,34(2):97.[doi:10.3760/cma.j.issn.1673-4114.2010.02.009]
HU Hong-yong,TANG Jian-lin,LI Yu-ying,et al.The value of combined tumor markers of CEA, CA19-9 and CA242 for diagnosis of patients with colorectal cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(1):97.[doi:10.3760/cma.j.issn.1673-4114.2010.02.009]
[4]渠浩,王振军,陈大志,等.18F-氟代脱氧葡萄糖正电子放射导向手术在结直肠癌治疗中的初步应用[J].国际放射医学核医学杂志,2006,30(3):145.
QU Hao,WANG Zhen-jun,CHEN Da-zhi,et al.The preliminary study using 18F-fluorodeoxyglucose positron-radioguided surgery for colorectal carcinoma operation[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(1):145.
[5]杨柳.组织多肽特异性抗原的临床意义[J].国际放射医学核医学杂志,2003,27(5):216.
YANG Liu.Clinical value of tissue polypeptide specific antigen[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(1):216.
[6]高骏,段玉清,于江,等.新型PET显像剂18F-FACBC在前列腺癌中的应用进展[J].国际放射医学核医学杂志,2017,41(4):288.[doi:10.3760/cma.j.issn.1673-4114.2017.04.010]
Gao Jun,Duan Yuqing,Yu Jiang,et al.Application of new PET imaging agent 18F-FACBC in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2017,41(1):288.[doi:10.3760/cma.j.issn.1673-4114.2017.04.010]
[7]田蓉蓉,薄云峰,张毅勋,等.18F-FDG PET/CT显像与结直肠癌治疗前分期的相关性研究[J].国际放射医学核医学杂志,2018,(1):9.[doi:10.3760/cma.j.issn.1673-4114.2018.01.002]
Tian Rong-rong,Bo Yunfeng,Zhang Yixun,et al.Correlation between 18F-FDG PET/CT and pretreatment staging of colorectal cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2018,(1):9.[doi:10.3760/cma.j.issn.1673-4114.2018.01.002]
[8]朱长春,冯国兴,董佳丽,等.应用生物信息学确定结直肠癌辐射抗性细胞的差异表达基因[J].国际放射医学核医学杂志,2018,(4):340.[doi:10.3760/cma.j.issn.1673-4114.2018.04.010]
Zhu Changchun,Feng Guoxing,Dong Jiali,et al.Identification of genes for radiation resistance in colorectal cancer cells using bioinformatics analysis[J].International Journal of Radiation Medicine and Nuclear Medicine,2018,(1):340.[doi:10.3760/cma.j.issn.1673-4114.2018.04.010]
[9]张伟,于丽娟.18F-FDG PET/CT与18F-FDG PET/MRI在卵巢癌临床应用中的进展[J].国际放射医学核医学杂志,2018,(5):441.[doi:10.3760/cma.j.issn.1673-4114.2018.05.010]
Zhang Wei,Yu Lijuan.Advances in clinical application of 18F-FDG PET/CT and 18F-FDG PET/MRI in ovarian cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2018,(1):441.[doi:10.3760/cma.j.issn.1673-4114.2018.05.010]